IQV - IQVIA Holdings Inc.
NYSE
->
Healthcare
->
Diagnostics & Research
Durham,
United States
Type: Equity
IQV price evolution
IQV
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1545 | $1444 | $1376 | |
| Short term investments | $133 | $131 | $120 | |
| Net receivables | $3250 | $3255 | $3426 | $3381 |
| Inventory | ||||
| Total current assets | $5632 | $5622 | $5651 | $5596 |
| Long term investments | $287 | $263 | $239 | |
| Property, plant & equipment | $772 | $768 | $791 | $819 |
| Goodwill & intangible assets | $19085 | $19241 | $19406 | |
| Total noncurrent assets | $20776 | $20923 | $21085 | |
| Total investments | $420 | $394 | $359 | |
| Total assets | $27180 | $26398 | $26574 | $26681 |
| Current liabilities | ||||
| Accounts payable | $3434 | $3313 | $3455 | $3564 |
| Deferred revenue | $1811 | $1914 | $1799 | |
| Short long term debt | $1167 | $717 | $718 | |
| Total current liabilities | $6992 | $6620 | $6448 | $6491 |
| Long term debt | $12293 | $12283 | $13023 | $13178 |
| Total noncurrent liabilities | $13064 | $13782 | $14078 | |
| Total debt | $13450 | $13740 | $13896 | |
| Total liabilities | $20213 | $19684 | $20230 | $20569 |
| Shareholders' equity | ||||
| Retained earnings | $5628 | $5343 | $4980 | $4692 |
| Other shareholder equity | -$826 | -$949 | -$911 | -$867 |
| Total shareholder equity | $6714 | $6344 | $6112 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1376 | $1216 | $1366 | $1814 |
| Short term investments | $120 | $93 | $111 | $88 |
| Net receivables | $3381 | $2960 | $2551 | $2410 |
| Inventory | ||||
| Total current assets | $5596 | $4981 | $4763 | $5090 |
| Long term investments | $239 | $162 | $164 | $162 |
| Property, plant & equipment | $819 | $863 | $903 | $953 |
| Goodwill & intangible assets | $19406 | $18741 | $18244 | $17859 |
| Total noncurrent assets | $21085 | $20356 | $19926 | $19474 |
| Total investments | $359 | $255 | $275 | $250 |
| Total assets | $26681 | $25337 | $24689 | $24564 |
| Current liabilities | ||||
| Accounts payable | $3564 | $645 | $2981 | $2813 |
| Deferred revenue | $1799 | $1797 | $1825 | $1252 |
| Short long term debt | $718 | $152 | $91 | $149 |
| Total current liabilities | $6491 | $5578 | $5241 | $4558 |
| Long term debt | $13178 | $12819 | $12347 | $12755 |
| Total noncurrent liabilities | $14078 | $13994 | $13406 | $13726 |
| Total debt | $13896 | $13011 | $12438 | $12904 |
| Total liabilities | $20569 | $19572 | $18647 | $18284 |
| Shareholders' equity | ||||
| Retained earnings | $4692 | $3334 | $2243 | $1277 |
| Other shareholder equity | -$867 | -$727 | -$406 | -$205 |
| Total shareholder equity | $6112 | $5765 | $6042 | $6001 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3896 | $3814 | $3737 | $3868 |
| Cost of revenue | $2488 | $2444 | $2478 | |
| Gross Profit | $1378 | $1326 | $1293 | $1390 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $509 | $508 | $556 | |
| Total operating expenses | $800 | $806 | $787 | $889 |
| Operating income | $520 | $506 | $501 | |
| Income from continuing operations | ||||
| EBIT | $601 | $503 | $548 | |
| Income tax expense | $65 | $75 | $49 | -$102 |
| Interest expense | -$157 | $163 | $166 | $181 |
| Net income | ||||
| Net income | $285 | $363 | $288 | $469 |
| Income (for common shares) | $363 | $288 | $469 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $14984 | $14410 | $13874 | $11359 |
| Cost of revenue | $9745 | $9382 | $9233 | $7500 |
| Gross Profit | $5239 | $5028 | $4641 | $3859 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $2053 | $2071 | $1964 | $1789 |
| Total operating expenses | $3262 | $3229 | $3248 | $3128 |
| Operating income | $1977 | $1799 | $1393 | $731 |
| Income from continuing operations | ||||
| EBIT | $2131 | $1767 | $1504 | $767 |
| Income tax expense | $101 | $260 | $163 | $72 |
| Interest expense | $672 | $416 | $375 | $416 |
| Net income | ||||
| Net income | $1358 | $1091 | $966 | $279 |
| Income (for common shares) | $1358 | $1091 | $966 | $279 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $363 | $288 | $469 | |
| Operating activities | ||||
| Depreciation | $269 | $264 | $316 | |
| Business acquisitions & disposals | -$104 | -$166 | -$30 | |
| Stock-based compensation | $48 | $56 | $45 | |
| Total cash flows from operations | $588 | $522 | $747 | |
| Investing activities | ||||
| Capital expenditures | -$118 | -$145 | -$179 | |
| Investments | $1 | -$3 | -$4 | |
| Total cash flows from investing | -$1134 | -$221 | -$314 | -$212 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$60 | -$232 | ||
| Net borrowings | -$253 | -$43 | -$186 | |
| Total cash flows from financing | -$503 | -$260 | -$106 | -$420 |
| Effect of exchange rate | $2 | -$6 | -$34 | $37 |
| Change in cash and equivalents | $196 | $101 | $68 | $152 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $1358 | $1091 | $966 | $279 |
| Operating activities | ||||
| Depreciation | $1125 | $1130 | $1264 | $1287 |
| Business acquisitions & disposals | -$915 | -$1335 | -$1463 | -$167 |
| Stock-based compensation | $217 | $194 | $170 | $95 |
| Total cash flows from operations | $2149 | $2260 | $2942 | $1959 |
| Investing activities | ||||
| Capital expenditures | -$649 | -$674 | -$640 | -$616 |
| Investments | -$44 | -$5 | -$5 | -$11 |
| Total cash flows from investing | -$1603 | -$2006 | -$2103 | -$796 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$1053 | -$1239 | -$465 | -$491 |
| Net borrowings | $752 | $936 | $30 | $309 |
| Total cash flows from financing | -$382 | -$329 | -$1235 | -$217 |
| Effect of exchange rate | -$4 | -$75 | -$52 | $31 |
| Change in cash and equivalents | $160 | -$150 | -$448 | $977 |
News
Fundamentals
| Market cap | $36.91B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 181.60M |
| Revenue | $15.31B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $1.41B |
| Revenue Q/Q | 4.28% |
| Revenue Y/Y | 3.10% |
| P/E ratio | 26.27 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 2.41 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $7.74 |
|---|---|
| ROA | 5.26% |
| ROE | N/A |
| Debt/Equity | 3.37 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.81 |
| Quick ratio | N/A |